Cost-Effectiveness Analysis of Prophylaxis Treatment Strategies to Reduce the Incidence of Febrile Neutropenia in Patients with Early-Stage Breast Cancer or Non-Hodgkin Lymphoma

OBJECTIVE: The objective of this study was to evaluate the cost effectiveness of no prophylaxis, primary prophylaxis (PP), or secondary prophylaxis (SP) with granulocyte colony-stimulating factors (G-CSFs), i.e., pegfilgrastim, lipegfilgrastim, filgrastim (6- and 11-day), or lenograstim (6- and 11-d...

Descripción completa

Detalles Bibliográficos
Autores principales: Fust, Kelly, Li, Xiaoyan, Maschio, Michael, Villa, Guillermo, Parthan, Anju, Barron, Richard, Weinstein, Milton C., Somers, Luc, Hoefkens, Caroline, Lyman, Gary H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2016
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5357483/
https://www.ncbi.nlm.nih.gov/pubmed/27928760
http://dx.doi.org/10.1007/s40273-016-0474-0

Ejemplares similares

Ejemplares similares